In the lung tissues, the triple treatment group was the only group showing a significant increase of Granzyme B, a critical component of the cytotoxic T cell response, suggestive of an enhanced anti-tumor immunity in lungs (Figure 6A). The gene discussed is GZMB; the disease is neoplasm.